View larger version (94K):
[in a new window]
|
Fig. 3. Without Eve, RP2 and a/pCC neurons show abnormal axonal morphologies. CNS
preparations from embryos carrying both transgenes
UAS- lacZ (microtubule-associated ßgal marker) and
RN2-Gal4 (RP2+a/pCC driver), in a wild-type background
(A,C,E,G,I,K,M,O), a  RP2A mutant background (eve null rescued
with RP2 element-deleted transgenes; B,D,F,H,J,L,N,P), in an
eveID19 background (Q) or in eveID19,
RP2A transheterozygotes (R), as indicated beside each row. (A,B)
Anti-ß-gal staining; overview of the CNS. Scale bar (in B): 50 µm.
(C,D) Anti-Eve staining (black) followed by anti-ß-gal staining (brown);
black arrows indicate RP2 neurons. The focal plane is that of the U/CQ
neurons, so that the RP2s are slightly out of focus. Note that RP2 is
abnormally close to aCC in the mutant. (E,F) Anti-ß-gal staining; higher
magnification view of A,B in the RP2 and aCC axonal focal plane. Note that
very few RP2 axons turn laterally (arrows) in the mutant. (G-J)
Anti-ß-gal staining (black) followed by anti-Fas2 staining (1D4 antibody,
brown); stage 13 (G,H) and stage 15 (I,J) are shown. In the mutant, RP2s often
extend an axon posteriorly, rather than anteriorly as in the wild type, along
the lateral longitudinal fascicle (arrow in H,J). Although the majority of
RP2s extend an axon anteriorly, which then either turns laterally at the pISN
(arrowhead in J), as in the wild type, or fails to turn at the ISN (arrowhead
in H; compare with the wild type in G,I), most of them do not exit the CNS
(see Table 1). Even those that
do exit the CNS fail to extend to the dorsal muscle field (see
Fig. 5). (K,L) Anti-ß-gal
staining; higher magnification view of A, B in the pCC axonal focal plane. The
pCC axons extend anteriorly beyond the next more anterior pCC cell body in the
wild type, while in the mutant, the pCC axons often cross the midline at the
anterior commissure (arrows). Note that there are small neurons extending
their axons laterally in the wild type. These are RP2 siblings, because at
earlier stages, they also stain for Eve (not shown). (M,N) Higher
magnification of K and D, respectively. Scale bar (in N): 5 µm. (O,P)
Anti-ß-gal staining; stage 12 CNSs are shown. In the wild type, the
positions of the aCC and pCC cell bodies (after their generation from GMC1-1a)
are well regulated; pCC is positioned either posteriorly (arrow) or
posteriorly and laterally (arrowheads) relative to aCC. This positioning is
disarrayed in the mutant; pCCs positioned posteromedially (wide arrow) or
directly laterally (open arrows) are indicated. (Q,R) Anti-ß-gal
staining; the temperature-sensitive eve allele ID19 kept at
the restrictive temperature during nervous system development after allowing
segmentation to occur at the permissive temperature (see Materials and methods
for details). (Q) eveID19 homozygous mutant; note that
many more axons extend laterally than in RP2A/RP2A (compare with
F), indicating that eveID19 does not act as a complete
null allele in the nervous system. (R) A single copy of
eveID19 with one copy of RP2A; note that the
phenotype is more severe than that of eveID19 homozygotes
(Q) and less severe than that of RP2A/RP2A (F): fewer pCC axons
crossed the midline and more axons turned laterally than in F. Scale bar (same
size as that in B): 20 µm in C,D; 30 µm in all other panels except
A,B,M,N.
|
